MSD

Focus: MSD is a small-molecule focused biotechnology company headquartered in Ireland with a diverse pipeline spanning oncology, infectious diseases, metabolic disorders, neurology, and cardiovascular indications. The company appears to be in early-stage development with a portfolio of clinical and preclinical programs.

Oncology Infectious Diseases Metabolic Diseases Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About MSD

AI assessmentNot Hiring

No open roles listed right now. Follow MSD to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Serial awakenings

Primary Insomnia

N/A

Clinical Trials (1)

NCT01960452A High Density EEG Comparison of Sleep Patterns in Insomnia

N/A

Help build intelligence for MSD

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diverse therapeutic area exposure across five major disease categories (oncology, infectious disease, metabolic, neurology, cardiovascular) enables broad skill development
Early-stage pipeline with 30 programs in Phase 1-3 development offers opportunity to shape clinical strategy and see compounds advance from concept through trials
Small-molecule expertise in high-value indications like hepatitis C, HIV, and oncology provides specialized technical depth

Watch Out For

Zero active job openings and recent 2022 founding suggest company is still operationalizing and may have limited near-term hiring
Pre-revenue status with no disclosed funding, financial data, or employee count creates significant uncertainty about runway, resources, and long-term viability
Sparse early-stage portfolio (only 1 Phase 1 program, 6 Phase 2, 2 Phase 3) with zero active trials listed indicates potential execution challenges or data quality concerns

Generated by Claude from MSD's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Interferon α-2b

Melanoma

N/A

Clinical Trials (1)

NCT00749684Efficacy and Safety of High-dose Interferon Alfa-2b (Intron A®) for the Adjuvant Treatment of Malignant Melanoma (Study P04083)

N/A

Observational Data Analysis in EuroSIDA (MK-0518-058)

HIV-1 Infections

N/A

Clinical Trials (1)

NCT01078233Observational Data Analysis in EuroSIDA (MK-0518-058)

N/A

Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseli

HIV Infections

N/A

Clinical Trials (1)

NCT01273142Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

N/A

placebo

Asthma

N/A

Clinical Trials (2)

NCT07554339A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

Phase 3

NCT01210170Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma

N/A

Care coordination tool

Lung Cancer

N/A

Clinical Trials (1)

NCT03694054Care Coordination in Oncology, Quality Among Patients With Lung Cancer and Their Caregivers

N/A

Comprehensive non invasive cardiovascular examination

Coronary Heart Disease

N/A

Liquid Biopsy

Metastatic Prostate Cancer

N/A

Clinical Trials (1)

NCT05885009Feasibility and Impact of Liquid Biopsy Genomic Profiling on Treatment Patients With Metastatic Prostate Cancer in Spain (SOLTI-2102)

N/A

Effectiveness and Feasibility of Self-Monitoring for Weight Management in Individuals with Mental Disorders Using Digital Intervention

Schizophrenia

N/A

Clinical Trials (1)

NCT05866107App and Body Fat Scale in the Management of Overweight Patients

N/A

PegIFN-2b

Hepatitis C, Chronic

N/A

Clinical Trials (1)

NCT00724893Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423)

N/A

Peginterferon alfa-2b

Hepatitis C

N/A

Clinical Trials (1)

NCT00724451Observational Study Assessing Chronic Hepatitis C Management in Clinical Practice in Italy (Study P05488 AM1)

N/A

Comprehensive non invasive cardiovascular examination

Coronary Heart Disease

N/A

Clinical Trials (1)

NCT01196273Cardiovascular Diseases in HIV-infected Patients HIV-HEART Study: 5 Years Follow-up

N/A

There are no interventions in this study. All participants complete online surveys.

Lung Cancer Patients

N/A

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

HIV Infections

N/A

Clinical Trials (1)

NCT01190124Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

N/A

Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

Escherichia Coli Infections

N/A

Clinical Trials (1)

NCT01324726Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms

N/A

Pembrolizumab

Neoplasms

N/A

Clinical Trials (1)

NCT02909348Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab

N/A

Caelyx

Ovarian Neoplasms

N/A

Clinical Trials (1)

NCT00743431Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)

N/A

Venous blood samples, anal swab samples, vaginal swab samples, high resolution anoscopy

Inflammatory Bowel Disease (IBD)

N/A

Clinical Trials (1)

NCT01364896Anal Human Papillomavirus in Inflammatory Bowel Disease Study

N/A

Study population

Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

N/A

Clinical Trials (1)

NCT03719027Prevalence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism : (Preva-CTEPH)

N/A

Human Papillomavirus Vaccine

Chronic Kidney Disease

N/A

Clinical Trials (1)

NCT00767897The Impact of the Human Papilloma Virus in Pediatric Chronic Kidney Disease, Dialysis, and Transplant Patients

N/A

A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving F

Head and Neck Cancer

N/A

Pain Quality Study

Low Back Pain

N/A

Clinical Trials (1)

NCT01321190Pain Quality Study

N/A

Sitagliptin

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT01354990A Post Marketing Safety Study of Sitagliptin (JANUVIA®) (MK-0431-234)

N/A

Sitagliptin

Type 2 Diabetes Mellitus

N/A

Clinical Trials (1)

NCT01062048Januvia Re-examination Study (MK-0431-181)

N/A

The Pathogenesis of Hepatitis C Virus Vertical Transmission

Hepatitis C

N/A

Clinical Trials (1)

NCT01921400The Pathogenesis of Hepatitis C Virus Vertical Transmission

N/A

RADOX' Reduced Abdominal Distension and Oxygen Delivery

Colorectal Cancer

N/A

Clinical Trials (1)

NCT02045680RADOX' Reduced Abdominal Distension and Oxygen Delivery

N/A

Doravirine

Virus-HIV

N/A

Clinical Trials (1)

NCT05322083HIV A6 Genome In ART Unsuccessful Patients On DOR

N/A

Care pathway unit

Colon Cancer

N/A

Clinical Trials (1)

NCT04235556Integrated Care Pathway in Oncology (PASSION)

N/A

Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervica

Cervical Cancer

N/A

Clinical Trials (1)

NCT06771193Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy

N/A

A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Lo

Non-small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT06467383A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

N/A

Golimumab Injection

Ankylosing Spondylitis

N/A

Clinical Trials (1)

NCT03557853Clinical and Radiological Manifestations of Coxitis in Patients With Ankylosing Spondylitis Treated With Golimumab

N/A

Elbasvir and Grazoprevir

Hepatitis C

N/A

Clinical Trials (1)

NCT03145623Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney Disease

N/A

Hybrid prehabilitation

Non-Small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT06866717Hybrid Prehabilitation Before Thoracic Surgery

N/A

Offering HPV vaccine

Cervical Cancer Screening

N/A

Clinical Trials (1)

NCT06995157Characteristics of Human Papillomavirus (HPV) Infections and HPV Vaccine Attitudes Among Slovenian Women After the Introduction of HPV Vaccination

N/A

None - Common practice

Stage IV Non-small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT03959137BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium

N/A

Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cel

Cytomegalovirus Infection

N/A

Clinical Trials (1)

NCT06916195Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation

N/A

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients

Cystic Fibrosis

N/A

Raltegravir

HIV

N/A

Clinical Trials (1)

NCT01978743Advanced Neuroimaging Evaluation of CNS Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen

N/A

Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage

Nasopharyngeal Carriage of S. Pneumoniae

N/A

Clinical Trials (1)

NCT01109108Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage

N/A

Acceptance of Human Papillomavirus Vaccination in Postpartum Women

Human Papilloma Virus

N/A

Clinical Trials (1)

NCT00730704Acceptance of Human Papillomavirus Vaccination in Postpartum Women

N/A

Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle Vaccine

HPV Vaccine

N/A

Clinical Trials (1)

NCT04711265Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

N/A

No intervention

HIV Prevention

N/A

Clinical Trials (1)

NCT05420207Implantable Long-Acting Pre-Exposure Prophylaxis For MSM

N/A

Systematic evaluation by an ID expert.

Clostridium Difficile

N/A

Clinical Trials (1)

NCT02951481Antimicrobial Stewardship Program for Clostridium Difficile Infection.

N/A

Technical Innovation Protocol for MR & US Plaque Imaging: Reproducibility.

Atherosclerosis

N/A

Clinical Trials (1)

NCT01196221Technical Innovation Protocol for MR & US Plaque Imaging: Reproducibility.

N/A

Online Migraine Treatment Optimization

Headache

N/A

Clinical Trials (1)

NCT02473692Facilitating Migraine Medication Adherence and Optimizing Medication Use

N/A

HIV-2 Genotypic Drug Resistance Testing using DBS

HIV-2 Infection

N/A

Leuprolide

Implantation, Embryo

N/A

Clinical Trials (1)

NCT01424618A Novel Approach to Endometrial Preparation in Recipients of Donor Eggs

N/A

Intron A

Melanoma

N/A

Clinical Trials (1)

NCT00723710Effect of Proactive Management of Side Effects on Treatment Compliance in Malignant Melanoma Patients on High-dose Intron A Therapy (Study P04600)

N/A

PegIntron pen

Hepatitis C, Chronic

N/A

Clinical Trials (1)

NCT00705107Adherence to Treatment With PegIntron Pen Plus Rebetol in Treatment-naïve Adult Patients With Hepatitis C in Romania (Study P04247)

N/A

Oral glucose tolerance

Prediabetes

N/A

Clinical Trials (1)

NCT02229487The Relationship Between Sleep and Glucose Tolerance in Prediabetes: the Role of GLP-1 in Short Sleepers